H43.822
Vitreomacular adhesion, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Vitreomacular adhesion (VMA) is a condition that affects the eye, specifically involving the vitreous (the clear gel that fills the eye) and the macula (the part of the retina responsible for central vision). When the vitreous gel pulls or sticks to the macula, it can cause visual disturbances. This condition is diagnosed in the left eye and is classified under the ICD-10 code H43.822. Understanding VMA is important for recognizing its potential effects on vision and seeking appropriate management when needed.
Causes & Symptoms
Clinical Causes: Age-related changes: As part of the natural aging process, the vitreous gel may shrink and pull away from the retina, sometimes causing adhesion. Posterior vitreous detachment: An occurrence where the vitreous separates from the retina but remains partially attached in some areas, leading to adhesion. Previous eye injuries or surgeries: Trauma or surgical procedures can alter the vitreous structure and contribute to adhesion formation. Myopia (nearsightedness): People with high degrees of myopia are more prone to vitreous adhesions due to elongation of the eyeball. Certain retinal diseases: Conditions that involve the retina may increase the likelihood of vitreomacular adhesion.
Key Symptoms: Blurred or distorted vision Presence of floaters: small specks or threads drifting in the visual field Metamorphopsia: visual distortion where straight lines appear bent or crooked Difficulty reading or performing tasks requiring sharp central vision Rarely, if the adhesion causes pulling on the retina, it may lead to visual loss or retinal detachment
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically confirmed through comprehensive eye examination, which includes ophthalmoscopy and imaging tests such as optical coherence tomography (OCT). OCT provides high-resolution cross-sectional images of the retina, allowing eye care professionals to visualize the vitreomacular interface and determine the presence and extent of adhesion.
Treatment Protocols: Management of vitreomacular adhesion depends on its severity and whether it is causing symptoms or complications. Options include: - Observation: If VMA is not affecting vision or causing any retinal problems, regular monitoring may be recommended. - Medical interventions: Pharmacologic agents such as ocriplasmin can sometimes facilitate separation of the vitreous from the retina. - Surgical procedures: Vitrectomy, a minimally invasive surgery to remove the vitreous gel, may be considered if symptoms are severe or if there’s a risk of retinal detachment or other complications. It is essential to discuss with an ophthalmologist to determine the most appropriate management based on individual circumstances.
Clinical Advice & FAQs
Billing Guidance
Is H43.822 a billable ICD-10 code?
Yes, H43.822 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H43.822?
Clinical documentation must specify the nature of Vitreomacular adhesion, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference